A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment

BACKGROUND: Nausea/vomiting (N/V) not related to anti-cancer treatment is common in patients with advanced cancer. The standard approach to management is to define a dominant cause, and treat with an antiemetic selected through pathophysiologic knowledge of emetic pathways. High rates of N/V control...

Descripción completa

Detalles Bibliográficos
Autores principales: Hardy, Janet, Skerman, Helen, Glare, Paul, Philip, Jennifer, Hudson, Peter, Mitchell, Geoffrey, Martin, Peter, Spruyt, Odette, Currow, David, Yates, Patsy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932901/
https://www.ncbi.nlm.nih.gov/pubmed/29720113
http://dx.doi.org/10.1186/s12885-018-4404-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932901/
https://www.ncbi.nlm.nih.gov/pubmed/29720113
http://dx.doi.org/10.1186/s12885-018-4404-8

Ejemplares similares